Related biomarkers, including soluble low-density lipoprotein receptor-related protein-1 (sLRP-1), have been implicated in both vascular [76] and amyloidogenic cascades [77]; however, current data do not support sLRP-1 as a CSVD-specific marker distinct from AD or other comorbid conditions. This evidence concerns the gene LRP1 and Alzheimer disease.